Skip to main content

Advertisement

SpringerLink
Log in

Pharmacogenetics as a tool in the therapy of schizophrenia

  • Published:
Pharmacy World and Science Aims and scope Submit manuscript

Abstract

Aim: This review summarises the present knowledge of associations between pharmacogenetics and therapeutic efficacy and side effects of antipsychotics to enable pharmacists to judge the applicability for a more tailor made therapy in patients with schizophrenia. Polymorphisms of Cytochrome P450 isoenzymes and neurotransmitter receptors involved in the efficacy and side effects of antipsychotics are highlighted in this review.

Method: A search was performed in Medline and EMBASE for the period 1995–August 2002. Also relevant references from the selected papers were incorporated.

Results: Poor metabolism with respect to CYP2D6 seems to be related with more pronounced extrapyramidal symptoms and more specifically with a higher incidence of tardive dyskinesia. The C/C-genotype for CYP1A2 results in smokers in a reduction of enzyme activity, but an effect on the incidence of tardive dyskinesia is controversial.

For dopamine D2 receptors the effect of the –141C Ins/ Del polymorphism on efficacy is not clear yet, although the Taq I polymorphism is associated with greater improvement of positive, but not negative symptoms in acute psychosis. The Gly9-allele of the dopamine D3 receptor is associated with the response to clozapine, but in studies in which the choice of antipsychotics is not restricted, the role of this polymorphism is unclear. The reverse is applicable to the dopamine D4.2/4.7 polymorphism.

For the 5-HT2A receptor the His452Tyr polymorphism is associated with response to clozapine, the 102 T/C polymorphism leads to equivocal results.

The polymorphism studied for 5-HT5A, 5-HT6, α1A- and α2A-receptors give no clear associations with the response to clozapine.

The polymorphism studied of the dopamine D2 and D4 receptor are not related to extrapyramidal adverse effects and side effects, respectively. The 9Gly-variant of the dopamine D3 receptor, the 102C-variant, but not the His452Tyr polymorphism of the 5-HT2A-receptor and the 23Ser-variant (for females only) of the 5-HT2C receptor seem to increase the susceptibility to tardive dyskinesia. Weight gain induced by antipsychotics seems to be associated with the –759C-allele of the 5-HT2C receptor.

Conclusion: The results show the first careful steps toward application of pharmacogenetics in a more individualised, tailor-made, pharmacotherapy. A precondition seems to be a multifactorial approach, as can be expected for multifactorial processes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • InstitutionalAuthorNameAmerican Psychiatric Association (1994) Diagnosis and statistical manual of mental disdorders EditionNumber4 American Psychiatric Association Washington DC

    Google Scholar 

  • V Özdemir VS Basile M Masellis JL Kennedy (2001) ArticleTitlePharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes. J Biochem Biophys Methods 47 151–7 Occurrence Handle10.1016/S0165-022X(00)00161-5 Occurrence Handle11179771

    Article  PubMed  Google Scholar 

  • Y Kawanishi H Tachikawa T Suzuki (2000) ArticleTitlePharmacogenomics and schizophrenia. Eur J Pharmacol 410 227–41 Occurrence Handle10.1016/S0014-2999(00)00817-7 Occurrence Handle1:CAS:528:DC%2BD3cXovFKjurg%3D Occurrence Handle11134672

    Article  CAS  PubMed  Google Scholar 

  • ML Dahl (2002) ArticleTitleCytochrome P450 phenotyping/genotyping in patients receiving antipsychotics. Useful aid to prescribing? Clin Pharmacokinetics 41 IssueID7 453–70 Occurrence Handle1:CAS:528:DC%2BD38Xmt12mtbs%3D

    CAS  Google Scholar 

  • VS Basile M Masellis RS McIntyre HY Meltzer JA Lieberman JL Kennedy (2001) ArticleTitleGenetic dissection of atypical antipsychotic- induced weight gain: novel preliminary data on the pharmacogenetic puzzle. J Clin Psychiatry 62(Suppl 23) 45–66

    Google Scholar 

  • DJ Touw DD Breimer (1997) ArticleTitleHet cytochrome P450-enzymsysteem. Een familie met acties, reacties en interacties. Deel 1. Pharmaceutisch Weekblad 132 IssueID28 948–63

    Google Scholar 

  • DJ Touw DD Breimer (1997) ArticleTitleHet cytochrome P450-enzymsysteem. Een familie met acties, reacties en interacties. Deel 2. Pharmaceutisch Weekblad 132 IssueID29 996–1009

    Google Scholar 

  • S Staddon MJ Arranz D Mancama I Mata RW Kerwin (2002) ArticleTitleClinical application of pharmacogenetics in psychiatry. Psychopharmacology 162 18–23 Occurrence Handle10.1007/s00213-002-1084-4 Occurrence Handle1:CAS:528:DC%2BD38Xmt1Cisrs%3D Occurrence Handle12107612

    Article  CAS  PubMed  Google Scholar 

  • J Kirchheiner K Børsen ML Dahl LF Gram S Kasper I Roots et al. (2001) ArticleTitleCYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages. Acta Psychiatrica Scand 104 173–92 Occurrence Handle10.1034/j.1600-0447.2001.00299.x Occurrence Handle1:CAS:528:DC%2BD3MXmvVekurg%3D

    Article  CAS  Google Scholar 

  • CAW Rijcken TB Monster JRBJ Brouwers LTW De Jong-van den Berg (2003) ArticleTitleChlorpromazine equivalents versus Daily Defined Dose: how to compare antipsychotic drug dose? J Clin Psychopharmacol 23 IssueID6 657–59 Occurrence Handle10.1097/01.jcp.0000096247.29231.3a Occurrence Handle1:CAS:528:DC%2BD3sXptVCnur4%3D Occurrence Handle14624195

    Article  CAS  PubMed  Google Scholar 

  • JF Wilson ME Weale AC Smith F Gratrix B Fletcher MG Thomas et al. (2002) ArticleTitlePopulation genetic structure of variable drug response. Nat Genet 29 IssueID3 265–69 Occurrence Handle10.1038/ng761

    Article  Google Scholar 

  • TG Schulze J Schumacher DJ Müller H Krauss D Alfter A Maroldt et al. (2001) ArticleTitleLack of association between a functional polymorphism of the cytochrome P450 1A2(CYP1A2) gene and tardive dyskinesia in schizophrenia. Am J Med Genet 105 498–501 Occurrence Handle10.1002/ajmg.1472 Occurrence Handle1:STN:280:DC%2BD3MvltVSquw%3D%3D Occurrence Handle11496364

    Article  CAS  PubMed  Google Scholar 

  • C Sachse J Brockmöller S Bauer I Roots (1999) ArticleTitleFunctional significance of a C-A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47 445–49 Occurrence Handle10.1046/j.1365-2125.1999.00898.x Occurrence Handle1:CAS:528:DyaK1MXivVCmtLo%3D Occurrence Handle10233211

    Article  CAS  PubMed  Google Scholar 

  • JR Hughes DK Hatsukami JE Mitchell LA Dahlgren (2004) ArticleTitlePrevalence of smoking among psychiatric outpatients. Am J Psychiatry 143 993–7

    Google Scholar 

  • JB Lohr K Flynn (1992) ArticleTitleSmoking and schizophrenia. Schizophrenia Res 8 93–102 Occurrence Handle10.1016/0920-9964(92)90024-Y Occurrence Handle1:STN:280:ByyD1M%2Fnt1c%3D

    Article  CAS  Google Scholar 

  • J Tauscher S Kapur (2001) ArticleTitleChoosing the right dose of antipsychotics in schizophrenia. Lessons from neuroimaging studies. CNS Drugs 15 IssueID9 671–78 Occurrence Handle1:CAS:528:DC%2BD3MXosF2ktLw%3D

    CAS  Google Scholar 

  • P Seeman T Tallerico (1998) ArticleTitleAntipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry 3 123–34 Occurrence Handle10.1038/sj.mp.4000336 Occurrence Handle1:CAS:528:DC%2BD3cXlslegsr4%3D Occurrence Handle9577836

    Article  CAS  PubMed  Google Scholar 

  • MJ Arinami M Gao H Hamaguchi M Toru (1997) ArticleTitleA functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Human Mol Genet 6 577–82 Occurrence Handle10.1093/hmg/6.4.577 Occurrence Handle1:CAS:528:DyaK2sXisFOku7Y%3D

    Article  CAS  Google Scholar 

  • E Jönsson MM Nöthen F Grünhage L Farde Y Nakashima P Propping et al. (1996) ArticleTitlePolymorphisms in the dopamine D2 receptor gene and their relationship to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4 290–6 Occurrence Handle10.1038/sj.mp.4000532

    Article  Google Scholar 

  • EP Noble K Blum T Ritchie A Montgomery PJ Sheridan (1991) ArticleTitleAllelic association of the D2 dopamine receptor gene with receptor binding characteristics in alcoholism. Arch Gen Psychiatry 48 648–54 Occurrence Handle1:STN:280:By6B1MfosVA%3D Occurrence Handle2069496

    CAS  PubMed  Google Scholar 

  • K Lundstrom MP Turpin (1996) ArticleTitleProposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest Virus system. Biochem Biophys Res Commun 225 1068–72 Occurrence Handle10.1006/bbrc.1996.1296 Occurrence Handle1:CAS:528:DyaK28Xlt1ajtb0%3D Occurrence Handle8780735

    Article  CAS  PubMed  Google Scholar 

  • EJ Gaitonde A Morris S Sivagnanasundaram PJ McKenna DM Hunt JD Mollon (1996) ArticleTitleAssessment of association of D3 dopamine receptor MscI polymorphism with schizophrenia: analysis of symptom ratings, family history, age at onset, and movement disorders. Am J Genet (Neuropsychiatric Genetics) 67 455–8 Occurrence Handle10.1002/(SICI)1096-8628(19960920)67:5<455::AID-AJMG3>3.0.CO;2-J Occurrence Handle1:STN:280:ByiD2c%2FoslU%3D

    Article  CAS  Google Scholar 

  • J Scharfetter HR Chaudry K Hornik K Fuchs W Sieghart S Kasper et al. (1999) ArticleTitleDopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients. Eur Neuropsychopharmacol 10 17–20 Occurrence Handle10.1016/S0924-977X(99)00044-9 Occurrence Handle1:CAS:528:DyaK1MXnsVKmsbg%3D Occurrence Handle10647091

    Article  CAS  PubMed  Google Scholar 

  • H Tol ParticleVan CM Wu H-C Guan K Ohara JR Bunzow O Civelli et al. (1992) ArticleTitleMultiple dopamine D4 receptor variants in the human population. Nature 358 149–52 Occurrence Handle10.1038/358149a0 Occurrence Handle1319557

    Article  PubMed  Google Scholar 

  • BF O’Dowd (1992) ArticleTitleRepeat sequences in the gene encoding the human D4 dopamine receptor. Gene 118 301–2 Occurrence Handle10.1016/0378-1119(92)90207-6 Occurrence Handle1:CAS:528:DyaK38Xmt1OnurY%3D Occurrence Handle1511906

    Article  CAS  PubMed  Google Scholar 

  • V Ashgari S Sanyal S Buchwaldt A Paterson V Jovanovic H Tol ParticleVan (1995) ArticleTitleModulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65 1157–65 Occurrence Handle7643093

    PubMed  Google Scholar 

  • RJ Baldessarini FR Frankenburg (1991) ArticleTitleClozapine- a novel antipsychotic agent. New Engl J Med 324 746–54 Occurrence Handle1:STN:280:By6C2cfmsFM%3D Occurrence Handle1671793

    CAS  PubMed  Google Scholar 

  • JE Leysen PMF Janssen L Heylen W Gommeren Pv Gompel AS Lesage et al. (1998) ArticleTitleReceptor interactions of new antipsychotics: relation to pharmacodynamic and clinical effects. Int J Psychiatry Clin Prac 2 S3–S17

    Google Scholar 

  • GF Busatto RW Kerwin (2002) ArticleTitlePerspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia. J Psychopharmacol 11 IssueID1 3–12

    Google Scholar 

  • MJ Arranz J Munro P Sham G Kirov RM Murray DA Collier et al. (1998) ArticleTitleMeta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophrenia Res 32 93–9 Occurrence Handle10.1016/S0920-9964(98)00032-2 Occurrence Handle1:STN:280:DyaK1cznvFGgsw%3D%3D

    Article  CAS  Google Scholar 

  • M Masellis VS Basile HY Meltzer JA Lieberman S Sevy FM Macciardi et al. (1998) ArticleTitleSerotonin Subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology 19 IssueID2 123–32 Occurrence Handle10.1016/S0893-133X(98)00007-4 Occurrence Handle1:CAS:528:DyaK1cXktVSis70%3D Occurrence Handle9629566

    Article  CAS  PubMed  Google Scholar 

  • MS Sodhi RM Murray (1997) ArticleTitleFuture therapies for schizophrenia. Expert Opin Ther Patents 7 151–65 Occurrence Handle1:CAS:528:DyaK2sXht1ShtL4%3D

    CAS  Google Scholar 

  • K Mihara T Kondo A Suzuki N Yasui S Ono K Otani et al. (2001) ArticleTitleNo relationship between -141C Ins/Del polymorphism in the promotor region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study. Psychiatry Res 101 33–8 Occurrence Handle10.1016/S0165-1781(00)00247-X Occurrence Handle1:CAS:528:DC%2BD3MXht1OrurY%3D Occurrence Handle11223117

    Article  CAS  PubMed  Google Scholar 

  • K Mihara A Suzuki T Kondo U Nagashima S Oho K Otani et al. (2000) ArticleTitleNo relationship between Taq1 A polymorphism of dopamine D-2 receptor gene and extrapyramidal adverse effects of selective dopamine D-2 antagonists, bromperidol, and nemonapride in schizophrenia: A preliminary study. Am J Med Genet 96 IssueID3 422–4 Occurrence Handle10.1002/1096-8628(20000612)96:3<422::AID-AJMG35>3.0.CO;2-5 Occurrence Handle1:STN:280:DC%2BD3czptVajug%3D%3D Occurrence Handle10898926

    Article  CAS  PubMed  Google Scholar 

  • B Lerer RH Segman H Fangerau AK Daly VS Basile R Cavallaro et al. (2002) ArticleTitlePharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology 27 IssueID1 105–19 Occurrence Handle10.1016/S0893-133X(02)00293-2 Occurrence Handle1:CAS:528:DC%2BD38Xktlymt7c%3D Occurrence Handle12062911

    Article  CAS  PubMed  Google Scholar 

  • E-C Tan S-A Chong R Mahendran F Dong CH Tan (2001) ArticleTitleSusceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor. Biol Psychiatry 50 144–7 Occurrence Handle10.1016/S0006-3223(01)01076-9 Occurrence Handle1:CAS:528:DC%2BD3MXlslCnsLo%3D Occurrence Handle11526996

    Article  CAS  PubMed  Google Scholar 

  • MJ Bannon JG Granneman G Kapatos (1995) The dopamine transporter: potential involvement in neuropsychiatric disorders. FE Bloom DJ Kupfer (Eds) Psychopharmacology 4th generation of progress. Raven Press New York 179–88

    Google Scholar 

  • RH Segman U Heresco-Levy B Finkel R Inbar T Neeman M Schlafman et al. (2000) ArticleTitleAssociation between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility. Psychopharmacology 152 408–13 Occurrence Handle10.1007/s002130000521 Occurrence Handle1:CAS:528:DC%2BD3MXpvFCq Occurrence Handle11140333

    Article  CAS  PubMed  Google Scholar 

  • YWY Yu SJ Tsai CH Lin CP Hsu KH Ynakg CJ Hong (1999) ArticleTitleSerotonin-6 receptor variant (C267T) and clinical response to clozapine. Neuroreport 10 1231–3 Occurrence Handle1:CAS:528:DyaK1MXjvVOnurc%3D Occurrence Handle10363930

    CAS  PubMed  Google Scholar 

  • M Masellis VS Basile HY Meltzer JA Lieberman S Sevy DA Goldman et al. (2001) ArticleTitleLack of association between the T/C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophrenia Res 47 49–58 Occurrence Handle10.1016/S0920-9964(00)00016-5 Occurrence Handle1:STN:280:DC%2BD3M3isFegtQ%3D%3D

    Article  CAS  Google Scholar 

  • MJ Arranz J Munro J Birkett A Bolonna D Mancama M Sodhi et al. (2000) ArticleTitlePharmacogenetic prediction of clozapine response. Lancet 355 1615–6 Occurrence Handle10.1016/S0140-6736(00)02221-2 Occurrence Handle1:CAS:528:DC%2BD3cXjs1Glu7w%3D Occurrence Handle10821369

    Article  CAS  PubMed  Google Scholar 

  • MJ Arranz S Staddon D Mancama J Munro S Osborne M Beperet et al. (2001) ArticleTitleResponse to olanzapine influenced by genes in neurotransmitter receptors. Am J Human Genet 69 2933

    Google Scholar 

  • R Joober C Benkelfat K Brisebois A Toulouse G Turecki S Lal et al. (1999) ArticleTitleT102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci 24 IssueID2 141–6 Occurrence Handle1:STN:280:DyaK1M3ivFShtQ%3D%3D Occurrence Handle10212557

    CAS  PubMed  Google Scholar 

  • K Ohara M Nagai K Tani Y Nakamura A Ino (1998) ArticleTitleFunctional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res 81 117–23 Occurrence Handle10.1016/S0165-1781(98)00092-4 Occurrence Handle1:CAS:528:DyaK1cXnvFKjtb4%3D Occurrence Handle9858029

    Article  CAS  PubMed  Google Scholar 

  • M Schäfer D Rujescu I Giegling A Guntermann A Erfurth B Bondy et al. (2001) ArticleTitleAssociation of short-term response to haloperidol treatment with a polymorphism in the dopamine D2 receptor gene. Am J Psychiatry 158 802–4 Occurrence Handle10.1176/appi.ajp.158.5.802 Occurrence Handle11329406

    Article  PubMed  Google Scholar 

  • MG Scordo E Spina P Romeo ML Dahl L Bertilsson I Johansson et al. (2000) ArticleTitleCYP2D6 genotype and antipsychotic-induced extrapyramidal side effects in schizophrenic patients. Eur J Clinical Pharmacology 56 679–83 Occurrence Handle10.1007/s002280000222 Occurrence Handle1:CAS:528:DC%2BD3MXlt1KntA%3D%3D

    Article  CAS  Google Scholar 

  • T Kapitany K Meszaros E Lenzinger SD Schindler C Barnas K Fuchs et al. (1998) ArticleTitleGenetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia. Schizophrenia Res 32 101–6 Occurrence Handle10.1016/S0920-9964(98)00038-3 Occurrence Handle1:STN:280:DyaK1cznvFGgsA%3D%3D

    Article  CAS  Google Scholar 

  • WJ Tamminga J Wemer B Oosterhuis A Boer Particlede S Vranckx BFH Drenth et al. (2003) ArticleTitlePolymorphic drug metabolism (CYP2D6) and utilization of psychotropic drugs in hospitalised psychiatric patients–a retrospective study. Eur J Clin Pharmacol 59 IssueID1 57–64 Occurrence Handle1:CAS:528:DC%2BD3sXjslWhsLg%3D Occurrence Handle12743673

    CAS  PubMed  Google Scholar 

  • VS Basile V Özdemir M Masellis ML Walker HY Meltzer JA Lieberman et al. (2000) ArticleTitleA functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: Association with tardive dyskinesia in schizophrenia. Mol Psychiatry 5 IssueID4 410–7 Occurrence Handle10.1038/sj.mp.4000736 Occurrence Handle1:CAS:528:DC%2BD3cXlslGjtb4%3D Occurrence Handle10889552

    Article  CAS  PubMed  Google Scholar 

  • MJ Arranz T Li J Munro X Liu R Murray DA Collier et al. (1998) ArticleTitleLack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response. Pharmacogenetics 8 IssueID6 481–4 Occurrence Handle1:CAS:528:DyaK1MXpvVyitw%3D%3D Occurrence Handle9918131

    CAS  PubMed  Google Scholar 

  • AK Malhotra RW Buchanan S Kim L Kestler A Breier D Pickar et al. (1999) ArticleTitleAllelic variation in the promoter region of the dopamine D2 receptor gene and clozapine response. Schizophrenia Res 36 92–3

    Google Scholar 

  • A Suzuki K Mihara T Kondo O Tanaka U Nagashima K Otani et al. (2000) ArticleTitleThe relationship between dopamine D2 receptor polymorphism at the Taq I A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients. Pharmacogenetics 2000 IssueID10 335–41 Occurrence Handle10.1097/00008571-200006000-00007

    Article  Google Scholar 

  • RP Ebstein F Macciardi U Heresco-Levy A Serretti D Blaine M Verga et al. (1997) ArticleTitleEvidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia. Human Hered 47 6–16 Occurrence Handle1:CAS:528:DyaK2sXhs1Khu74%3D

    CAS  Google Scholar 

  • S Shaikh DA Collier PC Sham D Ball K Aitchison H Vallada et al. (1996) ArticleTitleAllelic association between Ser-9-Gly polymorphisms in the dopamine D3 receptor gene and schizophrenia. Human Genet 97 714–9 Occurrence Handle10.1007/s004390050125 Occurrence Handle1:CAS:528:DyaK28XjvV2mtr4%3D

    Article  CAS  Google Scholar 

  • AK Malhotra D Goldman RW Buchanan W Rooney A Clifton MH Kosmidis et al. (1998) ArticleTitleThe dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response. Mol Psychiatry 3 72–5 Occurrence Handle10.1038/sj.mp.4000288 Occurrence Handle1:CAS:528:DC%2BD3cXls1Gls7k%3D Occurrence Handle9491816

    Article  CAS  PubMed  Google Scholar 

  • N Durany J Thome A Palomo P Foley P Riederer FF Cruz-Sanchez (1996) ArticleTitleHomozygosity at the dopamine D3 receptor gene in schizophrenic patients. Neurosci Lett 220 151–4 Occurrence Handle10.1016/S0304-3940(96)13251-1 Occurrence Handle1:CAS:528:DyaK2sXksVWjsA%3D%3D Occurrence Handle8994215

    Article  CAS  PubMed  Google Scholar 

  • MO Krebs F Sautel M-C Bourdel P Sokoloff J-C Schwartz H Lôo et al. (1998) ArticleTitleDopamine D3 receptor gene variants and substance abuse in schizophrenia. Mol Psychiatry 3 337–41 Occurrence Handle10.1038/sj.mp.4000411 Occurrence Handle1:CAS:528:DC%2BD3cXlslegsLc%3D Occurrence Handle9702743

    Article  CAS  PubMed  Google Scholar 

  • R Joober A Toulouse C Benkelfat S Lal D Bloom A Labelle et al. (2000) ArticleTitleDRD3 and DAT1 genes in schizophrenia: an association study. J Psychiatric Res 34 285–91 Occurrence Handle10.1016/S0022-3956(00)00018-2 Occurrence Handle1:STN:280:DC%2BD3M%2FnsVKrtA%3D%3D

    Article  CAS  Google Scholar 

  • JL Kennedy EA Billet FM Macciardi M Verga TJ Parsons HY Meltzer et al. (1995) ArticleTitleAssociation study of dopamine D3 receptor gene and schizophrenia. Am J Med Genet (Neuropsychiatric Genetics) 60 558–62 Occurrence Handle1:STN:280:BymH38zivFE%3D

    CAS  Google Scholar 

  • BM Cohen DJ Ennulat F Centorrino S Matthysse H Konieczna HM Chu et al. (1999) ArticleTitlePolymorphisms of the dopamine D4 receptor and response to antipsychotic drugs. Psychopharmacology (Berl) 141 IssueID1 6–10 Occurrence Handle10.1007/s002130050799 Occurrence Handle1:CAS:528:DyaK1MXhtFygurg%3D

    Article  CAS  Google Scholar 

  • HG Hwu CJ Hong YL Lee PC Lee SFC Lee (1998) ArticleTitleDopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia. Biol Psychiatry 44 483–7 Occurrence Handle10.1016/S0006-3223(98)00134-6 Occurrence Handle1:CAS:528:DyaK1cXmsV2ntLY%3D Occurrence Handle9777180

    Article  CAS  PubMed  Google Scholar 

  • S Shaikh D Collier R Kerwin LS Pilowski M Gill W-M Xu et al. (1993) ArticleTitleDopamine D4 receptor subtypes and response to clozapine. Lancet 341 116 Occurrence Handle10.1016/0140-6736(93)92594-J Occurrence Handle1:STN:280:ByyC3MnkvFU%3D

    Article  CAS  Google Scholar 

  • PA Rao D Pickar PV Gejman A Ram ES Gershon J Gelernter (1994) ArticleTitleAllelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch Gen Psychiatry 51 912–7 Occurrence Handle1:STN:280:ByqD3s7lsl0%3D Occurrence Handle7944879

    CAS  PubMed  Google Scholar 

  • M Rietschel D Naber H Oberländer R Holzbach R Fimmers K Eggerman et al. (1996) ArticleTitleEfficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene. Neuropsychopharmacology 15 491–6 Occurrence Handle10.1016/S0893-133X(96)00090-5 Occurrence Handle1:CAS:528:DyaK28XmvFWktL8%3D Occurrence Handle8914122

    Article  CAS  PubMed  Google Scholar 

  • V Özdemir M Masellis VS Basile W Kalow HY Meltzer JA Lieberman et al. (1999) ArticleTitleVariability in response to clozapine: potential role of cytochrome P450 1A2 and the dopamine D4 receptor gene. CNS Spectr 4 IssueID6 30–56

    Google Scholar 

  • M Arranz D Collier M Sodhi D Ball G Roberts J Price et al. (1995) ArticleTitleAssociation between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 346 281–2 Occurrence Handle10.1016/S0140-6736(95)92168-0 Occurrence Handle1:CAS:528:DyaK2MXntlKhtL0%3D Occurrence Handle7630250

    Article  CAS  PubMed  Google Scholar 

  • MJ Arranz DA Collier J Munro P Sham G Kirov M Sodhi et al. (1996) ArticleTitleAnalysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neurosci Lett 217 IssueID2–3 177–8 Occurrence Handle10.1016/0304-3940(96)13094-9 Occurrence Handle1:CAS:528:DyaK28XmslGns74%3D Occurrence Handle8916101

    Article  CAS  PubMed  Google Scholar 

  • AK Malhotra D Goldman N Ozaki A Breier RW Buchanan D Pickar (1996) ArticleTitleLack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. Am J Psychiatry 153 IssueID8 1092–4 Occurrence Handle1:STN:280:BymA3c3hvFc%3D Occurrence Handle8678181

    CAS  PubMed  Google Scholar 

  • JT Birkett MJ Arranz J Munro S Osbourn RW Kerwin D Collier (2000) ArticleTitleAssociation analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport 11 IssueID9 2017–20 Occurrence Handle1:CAS:528:DC%2BD3cXkslyntbY%3D Occurrence Handle10884063

    CAS  PubMed  Google Scholar 

  • AA Bolonna MJ Arranz J Munro S Osborne M Petouni M Martinez et al. (2000) ArticleTitleNo influence of adrenergic receptor polymorphism on schizophrenia and antipsychotic response. Neurosci Lett 280 65–8 Occurrence Handle10.1016/S0304-3940(99)01000-9 Occurrence Handle1:CAS:528:DC%2BD3cXosVOktA%3D%3D Occurrence Handle10696813

    Article  CAS  PubMed  Google Scholar 

  • R Kaiser F Klufmöller I Roots J Brockmöller (2002) ArticleTitleRelationship between adverse effects of antipsychotic treatment and dopamine D2 receptor polymorphisms in patients with schizophrenia. Mol Psychiatry 7 695–705 Occurrence Handle10.1038/sj.mp.4001054 Occurrence Handle1:CAS:528:DC%2BD38Xmt12qu78%3D Occurrence Handle12192613

    Article  CAS  PubMed  Google Scholar 

  • C-H Chen F-C Wei F-J Koong K-J Hsiao (1997) ArticleTitleAssociation of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia. Biol Psychiatry 41 827–9 Occurrence Handle10.1016/S0006-3223(96)00543-4 Occurrence Handle1:CAS:528:DyaK2sXisF2js74%3D Occurrence Handle9084902

    Article  CAS  PubMed  Google Scholar 

  • R Segman T Neeman U Heresco-Levy B Finkel L Karagichev M Schlafman et al. (1999) ArticleTitleGenotypic association between dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry 4 247–53 Occurrence Handle10.1038/sj.mp.4000511 Occurrence Handle1:CAS:528:DC%2BD3cXlvVWktr0%3D Occurrence Handle10395214

    Article  CAS  PubMed  Google Scholar 

  • VM Steen R Lovlie T MacEwan RG McCreadie (1997) ArticleTitleDopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol Psychiatry 2 139–45 Occurrence Handle10.1038/sj.mp.4000249 Occurrence Handle1:STN:280:ByiB28%2FhsVc%3D Occurrence Handle9106238

    Article  CAS  PubMed  Google Scholar 

  • M Rietschel H Kraus DJ Muller TG Schulze M Knapp K Marwinski et al. (2000) ArticleTitleDopamine D3 receptor variant and tardive dyskinesia. Eur Arch Psychiatry Clin Neurosci 250 31–5 Occurrence Handle1:STN:280:DC%2BD3c3gtFCnsw%3D%3D Occurrence Handle10738862

    CAS  PubMed  Google Scholar 

  • DL Liao YC Yeh HM Chen H Chen CJ Hong SJ Tsai (2001) ArticleTitleAssociation between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. Neuropsychobiology 44 95–8 Occurrence Handle10.1159/000054924 Occurrence Handle1:CAS:528:DC%2BD3MXms1ehtL8%3D Occurrence Handle11490179

    Article  CAS  PubMed  Google Scholar 

  • MM Garcia-Barcelo LC Lam GS Ungvari VK Lam WK Tang (2001) ArticleTitleDopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. J Neural Transm 108 IssueID6 671–7 Occurrence Handle10.1007/s007020170044 Occurrence Handle1:CAS:528:DC%2BD3MXlvFKkt74%3D Occurrence Handle11478419

    Article  CAS  PubMed  Google Scholar 

  • S-A Chong E-C Tan CH Tan Mythily YH Chan (2003) ArticleTitlePolymorphisms of dopamine receptors and tardive dykinesia among Chinese patients with schizophrenia. Am J Med Genet 116(1 Suppl) 51–4 Occurrence Handle10.1002/ajmg.b.10004

    Article  Google Scholar 

  • RH Segman U Heresco-Levy B Finkel T Goltser R Shalem M Schlafman et al. (2001) ArticleTitleAssociation between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry 6 225–9 Occurrence Handle10.1038/sj.mp.4000842 Occurrence Handle1:CAS:528:DC%2BD3MXhsFGlu7o%3D Occurrence Handle11317227

    Article  CAS  PubMed  Google Scholar 

  • GP Reynolds Z-J Zhang X-B Zhang (2002) ArticleTitleAssociation of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 359 2086–7 Occurrence Handle10.1016/S0140-6736(02)08913-4 Occurrence Handle1:CAS:528:DC%2BD38XkslGhs7Y%3D Occurrence Handle12086765

    Article  CAS  PubMed  Google Scholar 

  • VS Basile M Masellis SG Potkin JL Kennedy (2002) ArticleTitlePharmacogenomics in schizophrenia: the quest for individualized therapy. Human Mol Genet 11 IssueID20 2517–30 Occurrence Handle10.1093/hmg/11.20.2517 Occurrence Handle1:CAS:528:DC%2BD38XnvVems7Y%3D

    Article  CAS  Google Scholar 

  • H Lüllmann K Mohr A Ziegler D Bieger (2000) Color atlas of pharmacology EditionNumber2 Georg Thieme Verlag Stuttgart,Germany

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany

    Bob Wilffert

  2. Department of Clinical Pharmacy of Zorggroep Noorderbreedte-and De Tjongerschans, Leeuwarden, The Netherlands

    Bob Wilffert

  3. Department of Social Pharmacy, Pharmacoepidemiology & Pharmacotherapy, Groningen University Institute for Drug Exploration (GUIDE), Groningen, The Netherlands

    Rianne Zaal & Jacobus R.B.J. Brouwers

  4. Department of Clinical Pharmacy of Zorggroep Noorderbreedte and De Tjongerschans, Leeuwarden, The Netherlands

    Jacobus R.B.J. Brouwers

Authors
  1. Bob Wilffert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rianne Zaal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacobus R.B.J. Brouwers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bob Wilffert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilffert, B., Zaal, R. & Brouwers, J.R. Pharmacogenetics as a tool in the therapy of schizophrenia. Pharm World Sci 27, 20–30 (2005). https://doi.org/10.1007/s11096-004-1731-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-004-1731-4

Keywords

Search

Navigation